Growth Metrics

Celularity (CELU) Gross Profit (2020 - 2025)

Celularity (CELU) has disclosed Gross Profit for 5 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit fell 74.51% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.1 million, a 88.12% decrease, with the full-year FY2024 number at $39.2 million, up 480.77% from a year prior.
  • Gross Profit was $1.4 million for Q3 2025 at Celularity, up from $494000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $13.0 million in Q1 2024 to a low of -$6.7 million in Q4 2024.
  • A 5-year average of $3.6 million and a median of $2.6 million in 2021 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 2841.85% in 2024; the steepest drop was 175.23% in 2024.
  • Celularity's Gross Profit stood at $4.4 million in 2021, then soared by 96.39% to $8.7 million in 2022, then plummeted by 127.95% to -$2.4 million in 2023, then crashed by 175.23% to -$6.7 million in 2024, then skyrocketed by 120.74% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Gross Profit are $1.4 million (Q3 2025), $494000.0 (Q2 2025), and $7.9 million (Q1 2025).